Mounjaro covers two indications: "type 2 diabetes" and "weight loss," which were approved by the National Medical Products Administration in May and July 2024, respectively
[36] [37] In January 2026, the US Food and Drug Administration requested removal of a suicidal behavior and ideation warning from GLP-1 receptor agonist medications
Frequently Asked Questions What is semaglutide
There are many reasons why this might happen
lower or similar proportions of both men and women experienced events with semaglutide vs placebo, and p-values for interaction were nonsignificant (p = 0.46, p = 0.34 and p = 0.74, respectively, for each endpoint) (Fig
These peptides are typically dissolved in bacteriostatic water and have a thin, water-like consistency that flows easily through even 32G needles